Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?
Titel:
Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?
Auteur:
Mamidi, Rao N. V. S. Weng, Steve Stellar, Susan Wang, Charles Yu, Ning Huang, Tony Tonelli, Alfred P. Kelley, Michael F. Angiuoli, Anthony Fung, Man-Cheong